Bicalutamide is a non-steroidal antiandrogen medication primarily used to treat prostate cancer by competitively inhibiting the androgen receptor, thereby blocking the action of testosterone and slowing… Read more







![Chemical structure of Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl (1071213)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBicalutamide-Related-Compound-A-N-4-cyano-3-trifluoromethylphenyl-3-4-fluoro-phenylsulfinyl-1071213.png&w=3840&q=75)
![Chemical structure of Bicalutamide Related Compound B ((RS)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(3-fluorophenylsulfon (1071224)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBicalutamide-Related-Compound-B-RS-N-4-cyano-3-trifluoromethylphenyl-3-3-fluorophenylsulfon-1071224.png&w=3840&q=75)














![Chemical structure of N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F90357-51-0-N-4-Cyano-3-trifluoromethylphenyl-2-methyl-2-oxiranecarboxamide.png&w=3840&q=75)



Bicalutamide is a non-steroidal antiandrogen medication primarily used to treat prostate cancer by competitively inhibiting the androgen receptor, thereby blocking the action of testosterone and slowing the growth of cancer cells. To ensure drug safety, efficacy, and regulatory compliance, pharmaceutical laboratories rely on high-quality reference standards for Bicalutamide and its related compounds. This comprehensive collection supports essential activities such as impurity profiling, analytical method validation, and forced degradation studies. The product list includes various process-related impurities, stereoisomeric variants, and metabolites, as well as stable isotope labelled compounds. These materials are crucial for the accurate identification and quantification of potential contaminants or degradation products, helping to meet stringent international quality control guidelines during the oncology drug development process. By utilizing these characterized reference materials, researchers can maintain the high standards required for rigorous pharmaceutical analysis and toxicological evaluation.